Tag - takeda

 
 

TAKEDA

Takeda Pharmaceutical raised its full-year operating profit guidance to ¥265 billion from ¥225 billion, citing a stronger than expected first-half performance and updated currency assumptions.
BUSINESS
Oct 31, 2024
Japan's Takeda raises full-year profit forecast amid restructuring
Takeda raised its full-year operating profit guidance to ¥265 billion from ¥225 billion, citing a stronger than expected first-half performance.
Prime Minister Fumio Kishida speaks at a Lower House ethics committee hearing in Tokyo on Thursday.
JAPAN / Politics
Feb 29, 2024
Kishida apologizes over slush funds scandal at ethics committee meeting
In a rare appearance in front of the committee, the prime minister also vowed to implement political reforms in the wake of the scandal.
Takeda Pharmaceutical is in talks to make its dengue vaccine available in India.
BUSINESS / Companies
Feb 28, 2024
Takeda in regulatory talks to launch dengue vaccine in India
Takeda's dengue vaccine is currently available for children and adults in countries like Indonesia, Thailand, Argentina and Brazil.
Medics tend to COVID-19 patients at the intensive care unit of a hospital in Sofia, Bulgaria, in 2022.
JAPAN / Science & Health
Oct 7, 2023
Japan-led team identifies how severe COVID-19 cases develop
The research results are expected to facilitate the development of drugs to prevent serious COVID-19 complications.
Japan Times
BUSINESS
Mar 4, 2023
Japanese pharmaceutical firm Takeda lowers price of dengue shot in Brazil and Indonesia
The cost for Qdenga in Indonesia will be about one-third its European price, far lower than many other innovative vaccines, Takeda CEO Christophe Weber said in an interview.
Japan Times
BUSINESS / Companies
Dec 14, 2022
Takeda to pay up to $6 billion for Nimbus immune-therapy drug
After an initial $4 billion payment upfront, U.S.-based Nimbus is eligible for two additional $1 billion payments based on sales.
Japan Times
BUSINESS
Nov 12, 2022
Takeda to seek Japan approval for dengue vaccine
The firm's CEO said Takeda will prioritize regulatory approval in endemic countries, and that it will later seek approval in Japan to make it available for travelers.
Japan Times
JAPAN / Crime & Legal
Aug 26, 2022
Arrest over alleged bribery could be final whistle on career of Japan's sporting event ace
Since organizing a 1977 soccer event featuring Pele, Haruyuki Takahashi has been a towering figure in the sports business world.
Japan Times
LIFE / Food & Drink / New Wine Frontier
Feb 19, 2022
Snow country wine: Old vines and new vision
A senior vintner stakes his future on uprooting the past, while his daughter embraces the past to forge an exciting future.
Japan Times
JAPAN
Oct 1, 2021
Japan's Takeda says 'human error' caused contamination of Moderna vaccines
Japanese authorities in August suspended the use of three batches of Moderna shots containing 1.63 million doses after being notified of the contamination.
Japan Times
JAPAN
Sep 2, 2021
Moderna to recall COVID-19 doses in Japan over stainless steel contaminants
The health ministry said particles of stainless steel were found in suspended Moderna COVID-19 vaccines, but it did not expect they would pose an additional health risk.
Japan Times
JAPAN / Science & Health
May 23, 2021
Japan clinical trial of COVID-19 plasma therapy highlights slow-moving medical policy
Doctors are gearing up for clinical trials of convalescent plasma therapy, but many overseas hospitals have already moved on to other remedies.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?